240 related articles for article (PubMed ID: 29020342)
1. Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats.
Skrede S; González-García I; Martins L; Berge RK; Nogueiras R; Tena-Sempere M; Mellgren G; Steen VM; López M; Fernø J
Int J Neuropsychopharmacol; 2017 Dec; 20(12):1005-1012. PubMed ID: 29020342
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine depot exposure in male rats: Dose-dependent lipogenic effects without concomitant weight gain.
Fernø J; Ersland KM; Duus IH; González-García I; Fossan KO; Berge RK; Steen VM; Skrede S
Eur Neuropsychopharmacol; 2015 Jun; 25(6):923-32. PubMed ID: 25823694
[TBL] [Abstract][Full Text] [Related]
3. The role of thermogenesis in antipsychotic drug-induced weight gain.
Stefanidis A; Verty AN; Allen AM; Owens NC; Cowley MA; Oldfield BJ
Obesity (Silver Spring); 2009 Jan; 17(1):16-24. PubMed ID: 19107124
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats.
Zhang Q; Lian J; He M; Deng C; Wang H; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():172-80. PubMed ID: 24548587
[TBL] [Abstract][Full Text] [Related]
5. Effects of ovarian hormones on energy balance and brown adipose tissue thermogenesis.
Richard D
Am J Physiol; 1986 Feb; 250(2 Pt 2):R245-9. PubMed ID: 3946640
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine, not resperidone, exacerbates beta-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them.
Park S; Sang Mee Hong ; Il Sung Ahn ; Sung Hoon Kim
J Psychopharmacol; 2010 Jul; 24(7):1105-14. PubMed ID: 19965940
[TBL] [Abstract][Full Text] [Related]
7. Estrogen replacement reverses olanzapine-induced weight gain and hepatic insulin resistance in ovariectomized diabetic rats.
Park S; Hong SM; Ahn IL; Kim DS; Kim SH
Neuropsychobiology; 2010; 61(3):148-61. PubMed ID: 20173353
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects.
Skrede S; Martins L; Berge RK; Steen VM; López M; Fernø J
Int J Neuropsychopharmacol; 2014 Jan; 17(1):91-104. PubMed ID: 23919889
[TBL] [Abstract][Full Text] [Related]
9. Brown adipose tissue activity is modulated in olanzapine-treated young rats by simvastatin.
Liu X; Feng X; Deng C; Liu L; Zeng Y; Hu CH
BMC Pharmacol Toxicol; 2020 Jun; 21(1):48. PubMed ID: 32605639
[TBL] [Abstract][Full Text] [Related]
10. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
[TBL] [Abstract][Full Text] [Related]
11. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
[TBL] [Abstract][Full Text] [Related]
12. A role for hypothalamic AMP-activated protein kinase in the mediation of hyperphagia and weight gain induced by chronic treatment with olanzapine in female rats.
Sejima E; Yamauchi A; Nishioku T; Koga M; Nakagama K; Dohgu S; Futagami K; Kataoka Y
Cell Mol Neurobiol; 2011 Oct; 31(7):985-9. PubMed ID: 21681559
[TBL] [Abstract][Full Text] [Related]
13. Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance.
Guesdon B; Denis RG; Richard D
Behav Brain Res; 2010 Feb; 207(1):14-20. PubMed ID: 19788900
[TBL] [Abstract][Full Text] [Related]
14. Lipid-lowering effects of tetradecylthioacetic acid in antipsychotic-exposed, female rats: challenges with long-term treatment.
Skrede S; Fernø J; Bjørndal B; Brede WR; Bohov P; Berge RK; Steen VM
PLoS One; 2012; 7(11):e50853. PubMed ID: 23226405
[TBL] [Abstract][Full Text] [Related]
15. A role of neuropeptide CART in hyperphagia and weight gain induced by olanzapine treatment in rats.
Nakhate KT; Subhedar NK; Kokare DM
Brain Res; 2018 Sep; 1695():45-52. PubMed ID: 29775565
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats.
Choi S; DiSilvio B; Unangst J; Fernstrom JD
Life Sci; 2007 Sep; 81(12):1024-30. PubMed ID: 17822717
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.
Skrede S; Fernø J; Vázquez MJ; Fjær S; Pavlin T; Lunder N; Vidal-Puig A; Diéguez C; Berge RK; López M; Steen VM
Int J Neuropsychopharmacol; 2012 Mar; 15(2):163-79. PubMed ID: 21854679
[TBL] [Abstract][Full Text] [Related]
18. Regulation of UCP1, UCP2, and UCP3 mRNA expression in brown adipose tissue, white adipose tissue, and skeletal muscle in rats by estrogen.
Pedersen SB; Bruun JM; Kristensen K; Richelsen B
Biochem Biophys Res Commun; 2001 Oct; 288(1):191-7. PubMed ID: 11594772
[TBL] [Abstract][Full Text] [Related]
19. Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model.
Horska K; Kucera J; Drazanova E; Kuzminova G; Amchova P; Hrickova M; Ruda-Kucerova J; Skrede S
Biomed Pharmacother; 2024 Jul; 176():116763. PubMed ID: 38805968
[TBL] [Abstract][Full Text] [Related]
20. Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats.
Lazzari P; Serra V; Marcello S; Pira M; Mastinu A
Eur Neuropsychopharmacol; 2017 Jul; 27(7):667-678. PubMed ID: 28377074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
